HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Congenital neutropenia — Clinical Guidelines

Overview

Congenital neutropenia refers to a group of disorders characterized by a persistent low count of neutrophils, leading to recurrent infections and potential progression to myelodysplastic syndrome or acute myeloid leukemia 1 2.

Diagnosis

Persistent absolute neutrophil count <1.5 × 10^9/L 1

Evidence of recurrent bacterial infections 1 2

Bone marrow examination showing reduced myeloid progenitors and potential defects in apoptosis 3

Genetic testing to identify specific mutations (e.g., ELANE, HAX1, GFI1) 1

Management

First-line treatment: Granulocyte colony-stimulating factor (G-CSF) to increase neutrophil counts and reduce infection risk 3 2

Adjunctive treatments: Antibiotic prophylaxis to prevent infections 2

Stem cell transplantation (SCT): Considered curative for severe cases, particularly unrelated cord blood transplantation (UCBT) can be effective but requires careful immunosuppression 2

Special Populations

Pediatrics: Early initiation of G-CSF and consideration of SCT in severe cases 2 3

Comorbidities: Increased risk of developing myelodysplastic syndrome/acute myeloid leukemia necessitates close monitoring 2

Key Recommendations

Initiate G-CSF therapy to manage neutropenia and reduce infection risk in patients with congenital neutropenia (Evidence: Strong 3 2)

Evaluate stem cell transplantation, including UCBT, as a curative option for severe congenital neutropenia, especially in younger patients (Evidence: Moderate 2)

Regularly monitor for progression to myelodysplastic syndrome or acute myeloid leukemia due to the increased risk in congenital neutropenia patients (Evidence: Expert opinion)

References

1 Klein C. Molecular basis of congenital neutropenia. Haematologica 2009. link 2 Markel MK, Haut PR, Renbarger JA, Robertson KA, Goebel WS. Unrelated cord blood transplantation for severe congenital neutropenia: report of two cases with very different transplant courses. Pediatric transplantation 2008. link 3 Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellström-Lindberg E et al.. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004. link 4 Roos D, Kuijpers TW, Mascart-Lemone F, Koenderman L, de Boer M, van Zwieten R et al.. A novel syndrome of severe neutrophil dysfunction: unresponsiveness confined to chemotaxin-induced functions. Blood 1993. link 5 Pallarito K. Development deals can help finance growth. Modern healthcare 1990. link

Congenital neutropenia